In English | En español
Questions About Cancer? 1-800-4-CANCER

Find News Releases

Search For:
Between these dates:

All News Releases

Treatment helps young women preserve their fertility during breast cancer chemotherapy
NCI Press Release
(Posted: 05/30/2014) - Researchers have found that young women with breast cancer were able to better preserve their fertility during cancer treatments by using hormone-blocking drug injections that put them into temporary menopause. The results announced today at the annual meeting of the American Society of Clinical Oncology in Chicago are from the Prevention of Early Menopause Study (POEMS), a clinical trial sponsored by NCI.
View the article in Spanish

Tiny mutation triggers drug resistance for patients with one type of leukemia
NCI Cancer Center News
(Posted: 05/29/2014) - A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug. In a correspondence published online May 28 in the New England Journal of Medicine, they show how the mutation triggers resistance.

Stanford study could pave way to new treatment for rare jaw tumor
NCI Cancer Center News
(Posted: 05/27/2014) - Researchers have identified the mutations underlying a rare, understudied type of jaw tumor called ameloblastoma, and have also found FDA-approved drugs that may help treat the tumors.

UCSD scientists find gene mutation for aggressive form of pancreatic cancer
NCI Cancer Center News
(Posted: 05/27/2014) - Researchers at the University of California, San Diego School of Medicine have identified a mutated gene common to adenosquamous carcinoma tumors – the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer.

MD Anderson scientists discover potential new target for cancer immunotherapy
NCI Cancer Center News
(Posted: 05/27/2014) - Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments.

Albert Einstein College of Medicine study identifies how signals trigger cancer cells to spread
NCI Cancer Center News
(Posted: 05/27/2014) - Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a signaling pathway in cancer cells that controls their ability to invade nearby tissues in a finely orchestrated manner.

Memorial Sloan-Kettering study suggests double mastectomy often done unnecessarily
NCI Cancer Center News
(Posted: 05/23/2014) - A new study suggests double mastectomies may be performed unnecessarily in many women.

Cold Spring Harbor team validates potential new way to treat HER2-positive breast cancer
NCI Cancer Center News
(Posted: 05/22/2014) - Scientists at Cold Spring Harbor Laboratory today report a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer.

Mayo Clinic study shows virotherapy is promising against multiple myeloma
NCI Cancer Center News
(Posted: 05/22/2014) - In a proof of principle clinical trial, Mayo Clinic researchers have demonstrated that virotherapy — destroying cancer with a virus that infects and kills cancer cells but spares normal tissues — can be effective against the deadly cancer multiple myeloma.

Mayo Clinic researchers find that a molecule is linked to aggressive pancreatic cancer
NCI Cancer Center News
(Posted: 05/21/2014) - One sub-form, Rac1b, played a role in pancreatic cancer. The Mayo team began their research by investigating why pancreatic cancer cells produce matrix metalloproteinases.

< Previous  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21  Next >